Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06471374

Pathophysiology of Circadian Rhythm Delayed Sleep Wake Phase Disorder

The goal of this study is to understand factors that contribute to delayed sleep wake phase disorder (DSWPD). The investigators will examine whether patients with DSWPD exhibit alterations in circadian rhythms and sensitivity to light compared to healthy controls. The investigators will also test a new method of predicting circadian rhythms form a blood sample.

Recruiting

Interested in participating?

Request Info

Key information

Age range

16 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Colorado, Boulder, Colorado, United States

Loading trial locations.

About this study

  • The research parts of the study are 6.5 weeks long and the study, including screening visits, involves 6 in-person visits to the Boulder campus.
  • If participants qualify for the study and choose to participate, there will be two visits where participants will pick up research equipment to wear at home for 1-2 weeks of ambulatory monitoring before being studied in the laboratory. The first ambulatory monitoring session is for 2 weeks and the second is one week.
  • On the first ambulatory monitoring session the investigators will have participants answer questions about participant's mood and cognition.
  • On both ambulatory monitoring sessions, the investigators will also ask participants to wear a blood sugar monitor and track the timing of when participants eat using a phone app. The investigators will also have participants wear a wrist worn sleep and light monitor plus a daily sleep log and Google form of when participants go to bed and wake up.
  • Next will be a visit where participants will spend 66 hours (2.75 days) in the laboratory.
  • While living in the lab, participants will not be aware of the time of day (e.g., no clocks, internet, cell phones), and the investigators will schedule participant's activities.
  • The investigators will ask participants to remain seated in bed and awake for up to ~39 hours, with the head of the bed raised. Participants will be studied under dim light similar to candlelight.
  • The investigators will frequently take saliva samples for more than 24 hours when the investigators will ask participants to stay awake. The investigators will also take four blood samples.
  • The investigators will also ask participants to perform reaction time tests, tests of participant's ability to think, and to complete ratings of how participants feel multiple times each day that participants are in the lab.
  • The investigators will also record participant's brain wave activity, muscle activity, eye movements, and heart rate when participants stay awake and during ~9h sleep opportunities.
  • The investigators will then ask participants to sleep normally at home for ~2 weeks, followed by 1 week of ambulatory monitoring.
  • Finally, there will be a visit where participants will spend 48 hours (2 days) in the laboratory.
  • While living in the lab, participants will not be aware of the time of day (e.g., no clocks, internet, cell phones) and the investigators will schedule participant's activities.
  • The investigators will expose participants to different light levels (dim light similar to candlelight and typical room light).
  • The investigators will frequently take saliva samples.
  • The investigators will also ask participants to perform reaction time tests, tests of participant's ability to think, and to complete ratings of how participants feel multiple times each day that participants are in the lab.
  • The investigators will also record participant's brain wave activity, muscle activity, eye movements, and heart rate when participants are awake and while participants sleep.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Delayed sleep wake phase disorder diagnosis
  • Altitude history: currently residing at Denver altitude or higher
  • BMI normal to moderately overweight

Exclusion criteria

  • Recent medical condition
  • Psychiatric disorder
  • Sleep disorder
  • Medication use

Treatment and study plan

Circadian rhythm assessment

Behavioral

Participants will arrive approximately 8 hours before participant's scheduled bedtime to practice ability to think testing and a 9-hour sleep study. Participants will live in the laboratory for approximately 66 hours (2.75 days). Upon awakening in the morning, participants will start a routine of up to 39 hours of wakefulness, under bedrest conditions. Saliva will be sampled frequently and blood will be drawn 3 times. Reaction time, ability to think, and subjective rating tests will be performed frequently. Participants will be provided scheduled bathroom breaks when participants will use a commode next to the bed. Outside these scheduled bathroom breaks, participants will be provided a bedpan to use to go to the bathroom. At the end of the research procedures for Visit 4 participants will be given a recovery sleep opportunity and be discharged from the lab in the morning near participant's typical waketime.

Light sensitivity assessment

Behavioral

Participants will arrive in the afternoon to practice ability to think testing and a 9-hour sleep study. Participants will live in the laboratory for approximately 48 hours (2 days). Upon awakening in the morning, participants will be exposed to dim candlelight and then later in the day alternating intensities of dim and room light when we keep participants awake for up to 23 hours (We will ask participants to remain in bed seated for ~12.5 hours). Saliva will be sampled frequently. Reaction time, ability to think, and subjective rating tests will be performed frequently. Participants will then have a second 9-hour sleep opportunity.

Primary outcomes

  1. Core body temperature

    Time frame: Continuously for 1. up to 39 and 2. 23 hours

    Body temperature measured with a pill

  2. Glucose

    Time frame: Continuously for 1. up to 39 and 2. 23 hours

    Blood sugar levels

  3. Subjective sleepiness

    Time frame: Every 2 hours

    Self reported sleepiness

  4. Psychomotor vigilance

    Time frame: Every 2 hours

    Attention/Vigilance performance

Secondary outcomes

  1. Skin temperature

    Time frame: Continuously for 1. up to 39 and 2. 23 hours

    skin body temperature

  2. Melatonin

    Time frame: Hourly for 1. up to 39 hours and 2. every 20 minutes

    Melatonin levels in saliva

Study contacts

Contact information is provided by the study sponsor or research team.

Kenneth Wright, PhD

CONTACT

[email protected]

303-735-1923

Sponsors and collaborators

Lead sponsor

University of Colorado, Boulder

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)
  • Northwestern University

Registry information

Important dates

Study start
2024
Primary completion
2028
Study completion
2028
First posted
Jun 24, 2024
Registry last updated
Jun 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.